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Abstract
The rodent ventrobasal (VB) thalamus contains a relatively uniform population of thalamocortical (TC) neurons that receive
glutamatergic input from the vibrissae and the somatosensory cortex, and inhibitory input from the nucleus reticularis thalami (nRT).
In this study we describe c-aminobutyric acid (GABA)A receptor-dependent slow outward currents (SOCs) in TC neurons that are
distinct from fast inhibitory postsynaptic currents (IPSCs) and tonic currents. SOCs occurred spontaneously or could be evoked by
hypo-osmotic stimulus, and were not blocked by tetrodotoxin, removal of extracellular Ca
2+ or baﬁlomycin A1, indicating a non-
synaptic, non-vesicular GABA origin. SOCs were more common in TC neurons of the VB compared with the dorsal lateral geniculate
nucleus, and were rarely observed in nRT neurons, whilst SOC frequency in the VB increased with age. Application of THIP, a
selective agonist at d-subunit-containing GABAA receptors, occluded SOCs, whereas the benzodiazepine site inverse agonist b-CCB
had no effect, but did inhibit spontaneous and evoked IPSCs. In addition, the occurrence of SOCs was reduced in mice lacking the d-
subunit, and their kinetics were also altered. The anti-epileptic drug vigabatrin increased SOC frequency in a time-dependent
manner, but this effect was not due to reversal of GABA transporters. Together, these data indicate that SOCs in TC neurons arise
from astrocytic GABA release, and are mediated by d-subunit-containing GABAA receptors. Furthermore, these ﬁndings suggest that
the therapeutic action of vigabatrin may occur through the augmentation of this astrocyte–neuron interaction, and highlight the
importance of glial cells in CNS (patho) physiology.
Introduction
c-Aminobutyric acid (GABA)ergic signalling in the thalamus is central
to controlling the relay of sensory information to the cortex, and in
shaping behavioural state-dependent (patho)physiological cortico-tha-
lamocortical (TC) oscillations (Huguenard & McCormick, 2007). The
rodent somatosensory ventrobasal (VB) thalamus contains a relatively
uniform population of glutamatergic TC neurons, and unlike most
thalamic nuclei is devoid of GABAergic interneurons (Barbaresi et al.,
1986; Harris & Hendrickson, 1987). Instead, inhibitory input originates
from the nucleus reticularis thalami (nRT), which contains only
GABAergic neurons (Spreaﬁco et al., 1991). TC neurons of the VB
exhibit two types of GABAA receptor-mediated inhibition: classical
fast inhibitory postsynaptic currents (IPSCs), generated by synaptic
receptors; and a persistent or tonic current generated by a population of
extrasynaptic receptors that are activated by ambient GABA (Brown
et al., 2002; Belelli et al., 2005; Cope et al., 2005, Cope et al., 2009;
Jia et al., 2005; Chandra et al., 2006; Peden et al., 2008). Importantly,
different receptor subtypes underlie the two types of inhibition,
synaptic receptors contain a1b2c2-subunits, whereas a4b2d-subunits
comprise extrasynaptic receptors (Jia et al., 2005; Herd et al., 2009).
Indeed, the d-subunit is located exclusively extrasynaptically and
conveys properties on these receptors ideally suited to the generation of
tonic currents, particularly slow desensitization and a high afﬁnity for
GABA (Saxena & Macdonald, 1994). Despite this high afﬁnity, GABA
itself is only a partial agonist at d-subunit-containing receptors,
compared with the hypnotic THIP (Gaboxadol), which is a full,
selective agonist at these receptors (Brown et al., 2002; Ebert et al.,
2006; Storustovu & Ebert, 2006). Given the molecular, pharmacolog-
ical and anatomical distinctions between synaptic and extrasynaptic
GABAA receptors, they most likely subserve different functions in
thalamic (patho)physiological processes (e.g. Cope et al., 2009).
Astrocytes are already known to play pivotal roles in the regulation
of GABAergic signalling in the somatosensory thalamus as they are the
only cell type in this rodent nucleus to express GABA uptake
transporters (De Biasi et al., 1998). They therefore form a crucial link
in the GABA–glutamine pathway with their uptake of GABA and its
subsequent catabolism to glutamine, which is then supplied to nRT
afferent presynaptic terminals.
Despite substantial interest in the identity of GABA targets in the
thalamus, the sources of GABA that activate GABAA receptors in TC
neurons of the VB have not been thoroughly explored. Whilst it is
clear that synaptic receptors are directly activated by the vesicular of
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these terminals is the sole source of ambient GABA for extrasynaptic
receptors has yet to be determined. Non-synaptic sources of GABA,
including the reversal of GABA transporters (GATs; Wu et al., 2001,
2003, 2007), have been implicated in other brain regions and, in the
olfactory bulb, astrocytes release GABA, probably via a volume-
regulated anion channel mechanism (Kozlov et al., 2006). In the VB
thalamus, astrocytes can also release gliotransmitters, most notably
glutamate that can generate slow inward currents (SICs) in TC neurons
and modulate their function (Parri et al., 2001). However, the
possibility that astrocytes are a source of GABA in the thalamus has
not been evaluated. In this study, we describe spontaneous, transient,
non-synaptic slow outward currents (SOC) in TC neurons that are
generated by the release of GABA from astrocytes. Despite being
transient, SOC are not mediated by synaptic receptors but by d-
subunit-containing extrasynaptic GABAA receptors, and are upregu-
lated by the anti-epileptic vigabatrin.
Materials and methods
All procedures were carried out in accordance with the UK Animals
(Scientiﬁc Procedures) Act 1986 and associated procedures.
Slice preparation
Experiments were performed on postnatal day (P)10–23 for male
Wistar rats, and P27–40 for male and female d-subunit knockout mice
(d KO) and wild-type (WT) littermates. d KO and WT mice were
genotyped as described previously (Cope et al., 2009). Horizontal
slices (300–350 lm) of VB thalamus were prepared as described
previously (Parri et al., 2001) in ice-cold, continuously oxygenated
(95% O2:5 %C O 2) modiﬁed artiﬁcial cerebrospinal ﬂuid (ACSF) of
composition (in mm): NaCl, 126; NaHCO3, 26; KCl, 1; KH2PO4,
1.25; MgSO4, 5; CaCl2, 1; glucose, 10. Slices were then maintained at
room temperature (20 – 24 C) in this solution for a recovery period of
1 h before experimental use.
Solutions
The standard, continuously oxygenated (95% O2:5 %C O 2) ACSF used
in this study contained (in mm): NaCl, 126; NaHCO3, 24; KCl, 2.5;
KH2PO4, 1.25; MgSO4, 1; CaCl2, 2; glucose, 10; unless otherwise
stated.Hypo-osmoticstimuluswasa20%decreaseinACSFosmolarity.
For experiments where glutamatergic SICs were recorded, Mg
2+ was
omitted to enhance detection (Parri et al., 2001). Tetrodotoxin (TTX)
was included in ACSF and hypo-osmotic (h)ACSF in all experiments,
except where IPSCs were recorded, and current-clamp experiments.
Chemicals for ASCF preparation were obtained from Sigma (St Louis,
MO,USA).PharmacologicalcompoundswereincludedintheACSFas
stated in the text. In the case of Baﬁlomycin incubation, slices were
pretreatedinstorageACSFcontaining45 lmBaﬁlomycinA1for1–2 h
priortorecording.Drugswereobtainedfromthefollowingsources:(±)-
c-vinyl GABA (vigabatrin), 4,5,6,7-tetrahydroisoxazolo[5,4-c]-pyri-
din-3-ol (THIP), (5S,10R)-(+)-5-methyl-10,11-dihydro-5H-dibenzo
[a,d] cyclohepten-5,10-imine maleate (MK801), (2S)-2-amino-
2-[(1S,2S)-2-carboxycycloprop-1-yl]-3-(xanth-9-yl) propanoic acid
(LY341495), d-())-2-amino-5-phosphonopentanoic acid (D-AP5),
baﬁlomycin A1, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), 2,3-
dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulphonamide
(NBQX), (RS)-a-methyl-4-phosphonophenylglycine (MPPG), 3-((2-
methyl-1,3-thiazol-4-yl) ethynyl) pyridine hydrochloride (MTEP), 7-
(hydroxyimino) cyclopropa[b] chromen-1a-carboxylate ethyl ester
(CPCCOEt), butyl b-carboline-3-carboxylate (b-CCB), 1-(2-[([diphe-
nylmethylene]imino)-oxy]ethyl)-1,2,5,6-tetrahydro-3-pyridinecarboxy
lic acid hydrochloride (NO711) and 1-[2-[tris(4-methoxyphenyl)meth
oxy]ethyl]-(S)-3-piperidinecarboxylic acid (SNAP5114) were obtained
from Tocris (Bristol, UK); TTX and 2-(3-carboxypropyl)-3-amino-6-(4
methoxyphenyl)pyridazinium bromide (SR95531) were obtained from
Ascent (Weston-super-Mare, UK); kynurenic acid was obtained from
Sigma-Aldrich (Poole, Dorset, UK).
Electrophysiological recordings
The recording chamber and manipulators were mounted on a moveable
bridge (Luigs and Neumann, Ratingen, Germany). Slices were visual-
ized by DIC using a Nikon FN1 microscope with a · 40 0.8 NAwater
dipping lens. Patch-clamp recordings of SOCs were made at room
temperature(20–24 C),orat33 ± 1  Cwhereindicated,usingpipettes
(2–4 MX) containing a high Cl
) internal solution of composition (in
mm): KCl, 125; NaCl, 10; MgCl2, 2; CaCl2, 1; HEPES, 10; EGTA, 10;
Na2ATP, 4; GTP, 0.3. For experiments in d KO and WT mice, pipettes
contained (in mm): CsCl, 130; MgCl2, 2; Mg-ATP, 4; Na-GTP, 0.3;
HEPES, 10; EGTA, 0.1. To block possible contamination by N-methyl-
d-aspartate (NMDA) receptor-mediated SICs, either kynurenic acid
(3 mm) was included in the ACSF, or MK801 (1 mm) was included in
the patch solution (Berretta & Jones, 1996). Current traces from such
recordings are displayed inverted to maintain the convention of
GABAergicSOCs being outward. Experiments aimed at concomitantly
recording both SICs and SOCs and investigating the physiological
impact of SOC-mediated hyperpolarizations in current-clamp mode
were conducted using intracellular solution containing (in mm):
KMeSO4, 120; KCl, 5; HEPES, 10; EGTA, 0.1; Na2ATP, 4; GTP, 0.5.
Intracellular Cl concentration (5 mm) was included to set physiological
ECl in these cells (Ulrich & Huguenard, 1997). Tonic current was
measuredbyrapidlyintroducingtheGABAAantagonistSR95531tothe
recording chamber and measuring the resultant change in holding
current. Synaptic stimulation was achieved with a computer-controlled
constant current-isolated stimulator (STG1002; Multichannel Systems,
Germany) and bipolar electrodes placed on the internal capsule.
Neuronal currents were recorded using a Multiclamp 700B ampliﬁer,
digitized with a Digidata 1440A, and acquired and analysed using
pClamp software (Molecular Devices, CA, USA). IPSCs and SOCs
were analysed using the Event Detection protocols in Clampﬁt. Events
were classed as SOCs if their amplitude was > 20 pA and their time to
peakwas> 20 ms.DatawereexportedtoSigmaplot(Jandel)forfurther
analysis and plotting.
Statistics
All quantitative data in the text and ﬁgures are presented as
mean ± SEM. Signiﬁcance was calculated using unpaired or paired
Student’s t-test as appropriate. Kolmogorov–Smirnov tests were used
for population distribution comparisons. Linear correlations were
tested using Spearman’s Rank correlation. The statistical signiﬁcance
in ﬁgures is presented as *P < 0.05, **P < 0.01, ***P < 0.005.
Results
Astrocytic GABA release generates SOCs via GABAA receptors
Patch-clamp recordings were made from TC neurons in the VB
thalamus at ages P10–23. In addition to previously described
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receptors by astrocytically derived glutamate (Fig. 1A; Parri et al.,
2001), in some experiments (25 out of 42 recordings) we were able to
concomitantly record spontaneous, transient outward currents that had
very slow rise times and durations of hundreds of milliseconds
(Fig. 1A). Because of their similarity to the SOCs previously
described in the olfactory bulb (Kozlov et al., 2006), we adopted
the nomenclature of Kozlov et al. to identify them. The observed
incidence of spontaneous SOCs (sSOCs; 0.02 ± 0.01 SOCs⁄min) was
signiﬁcantly lower than that of sSICs (0.10 ± 0.03 SICs⁄min;
P < 0.05; Fig. 1A).
To focus on these outward inhibitory currents, subsequent exper-
iments were performed using pipettes containing high Cl
) in order to
isolate and enhance the detection of Cl
)-mediated currents (see
Materials and methods). Under such conditions, spontaneous IPSCs
were readily observed, as described previously (Le Feuvre et al.,
1997). IPSCs had a mean frequency of 15.60 ± 4.21 Hz (n =5
neurons), a mean time to peak of 2.45 ± 0.14 ms and mean amplitude
of 80.70 ± 4.66 pA (n = 250 events, pooled from ﬁve neurons;
Fig. 1B). IPSC frequency was signiﬁcantly lower in the presence of
TTX (1 lm) to block action potential-dependent GABA release
(21.96 ± 5.95% of control, n = 11 neurons; P < 0.05), and following
the removal of Ca
2+ from the ACSF to block voltage-dependent Ca
2+
entry (3.40 ± 3.00% of control, n = 5 neurons; P < 0.05; Fig. 1C).
Furthermore, application of the selective GABAA receptor antagonist
SR95531 (25 lm) abolished all IPSCs (n = 4 neurons; Fig. 1C). Thus,
conventional synaptic GABA release, presumably from the axon
terminals of nRT neurons, underlies the generation of IPSCs in TC
neurons of the VB.
In addition to spontaneous IPSCs, sSOCs could also be recorded
using pipettes containing high Cl
). The mean amplitude of the sSOCs
(111.30 ± 31.27 pA, n = 52 events) was not signiﬁcantly different to
that of IPSCs, and the distribution of peak amplitudes was also not
different (both P > 0.05; Fig. 1B). However, the mean time to peak
was signiﬁcantly slower (108.90 ± 34.53 ms, n = 52 events;
P < 0.001) and the distribution of rise times was also signiﬁcantly
different compared with IPSCs (P < 0.001; Fig. 1B). In complete
contrast to IPSCs, however, the frequency of sSOCs was not affected
by application of TTX (control – 0.29 ± 0.16⁄min; TTX –
0.25 ± 0.06⁄min, n = 9 neurons; P > 0.05) or the removal of
extracellular Ca
2+ (122.15 ± 63.56% of control, n = 6 neurons;
Fig. 1C), indicating a non-synaptic origin. To further investigate the
source of GABA responsible for generating SOCs, we treated slices
with baﬁlomycin A1, a depletor of vesicular neuro- and glio-
transmitter release. Application of baﬁlomycin A1 did not signiﬁcantly
affect the frequency of sSOCs (control 0.27 ± 0.09⁄min, n =1 9
neurons; baﬁlomycin 0.38 ± 0.14⁄min, n = 18 neurons; P > 0.05) or
their amplitude (control 109.60 ± 18.58 pA, n = 24 neurons; baﬁlo-
mycin 137.12 ± 11.34 pA, n = 10 neurons; P > 0.05), indicating that
SOCs are dependent on a non-vesicular GABA release mechanism.
sSOC frequency was also not affected by the combined block of
ionotropic and metabotropic glutamate receptors following the
application of D-AP5 (50 lm), NBQX or CNQX (20 lm), MTEP
(10 lm), CPCCOEt (100 lm), LY341495 (2 lm) and MPPG
(100 lm; control – 0.24 ± 0.06⁄min, n = 9 neurons; antagonists –
0.21 ± 0.07⁄min, n = 5 neurons). However, like IPSCs, sSOCs were
completely abolished by the GABAA receptor antagonist SR95531
(n = 5 neurons; Fig. 1C).
The incidence of sSOCs was low, with events only occurring every
few minutes. We therefore attempted to increase their frequency by
applying a hypo-osmotic stimulus, as described previously in the
olfactory bulb (Kozlov et al., 2006). Application of hACSF elicited
evoked SOCs (eSOCs) at a frequency of 1.55 ± 0.43⁄min (n =1 4
neurons; P < 0.001 compared with sSOC frequency; Fig. 2A). The
mean rise time and mean amplitude of eSOCs (136.97 ± 19.66 ms and
134.19 ± 13.21 pA, respectively, n = 14 neurons) were not signiﬁ-
cantly different to sSOCs recorded in the same neurons
(100.01 ± 19.65 ms and 109.60 ± 18.58 pA, respectively; both
P > 0.05; Fig. 2A). However, the population distributions for rise
times and peak amplitudes were signiﬁcantly different (P < 0.05 and
P < 0.005, respectively), with the eSOC population containing larger,
slower events (Fig. 2A). Bath application of SR95531 following
hACSF application not only blocked all eSOCs but also revealed a
large tonic GABAA receptor-mediated current compared with normal,
control ACSF (control – 14.30 ± 7.06 pA, n = 8 neurons; hACSF –
168.10 ± 28.36 pA, n = 8 neurons; P < 0.005; Fig. 2A). Thus,
GABA release caused by hypo-osmotic stimulation not only increases
the incidence of SOCs but also contributes to tonic GABAA inhibition.
Application of SR95531 before the hypo-osmotic stimulus prevented
the generation of eSOCs (control – 0.67 ± 0.14 mC, n = 8 neurons;
SR95531 – 0.06 ± 0.04 mC, n = 5 neurons; P < 0.01; Fig. 2B),
conﬁrming that eSOCs, like sSOCs, are exclusively mediated by
GABAA receptors.
In summary, these results show that SOCs are GABAA receptor-
mediated events that have markedly different properties to GABAA
receptor-mediated IPSCs, notably occurrence, onset and duration
(Figs 1 and 2). In addition, whereas IPSCs are sensitive to TTX,
external Ca
2+ concentration and baﬁlomycin A1, SOCs are insensitive
to all three of these manipulations. Thus, IPSCs arise due to
conventional vesicular GABA release from neuron terminals, but
SOCs are dependent upon an alternate GABA source that is non-
synaptic and non-vesicular. These data, together with the sensitivity of
SOCs to hypo-osmotic stimulation, suggest that SOCs are generated in
response to the release of GABA from astrocytes, probably through a
volume-regulated anion channel mechanism as previously implicated
in the olfactory bulb (Kozlov et al., 2006).
Nucleus-speciﬁc distribution and developmental proﬁle
of SOCs
To determine the functional expression of SOCs in the thalamus, we
compared sSOCs and eSOCs in thalamic nuclei that have different
anatomical and functional properties at the same age (P18–23) – the
VB nucleus, which receives somatosensory input and is comprised
solely of glutamatergic TC neurons (Barbaresi et al., 1986; Harris &
Hendrickson, 1987); the dorsal lateral geniculate nucleus (dLGN),
which receives visual input and contains a population of GABAergic
interneurons in addition to TC neurons (Ohara et al., 1983); and the
nRT, a thalamic nucleus comprised solely of GABAergic neurons
(Spreaﬁco et al., 1991; Fig. 3A). sSOCs were most prevalent in the
VB thalamus (0.20 ± 0.07⁄min, n = 8 neurons), followed by the
dLGN (0.03 ± 0.02⁄min, n = 9 neurons) and then the nRT (0.02 ±
0.02⁄min, n = 4 neurons; Fig. 2A and B). eSOCs also followed the
same pattern, being most common in the VB (2.35 ± 0.63⁄min, n =8
neurons), followed by the dLGN (0.53 ± 0.18⁄min, n = 9 neurons)
and then the nRT (0.20 ± 0.04⁄min, n = 5 neurons; Fig. 3A and B).
These data suggest that the VB has the greatest potential for non-
synaptic astrocytic GABA signalling, but also the greatest functional
impact, as the total charge carried by eSOCs following hACSF
application in the VB thalamus was signiﬁcantly greater than in both
the dLGN and the nRT (VB – 0.67 ± 0.14 mC, n = 8 neurons; dLGN
– 0.19 ± 0.06 mC, n = 7 neurons; nRT – 0.03 ± 0.02 mC, n =4
neurons; VB vs. dLGN, P < 0.01; VB vs. nRT, P < 0.01; Fig. 3B).
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of the VB. sSOC frequency was signiﬁcantly lower in TC neurons at
P10 compared with P20 (P10 – 0.30 ± 0.01⁄min, n = 19 neurons; P20
– 0.40 ± 0.05⁄min, n = 11 neurons; P < 0.01; Fig. 3C). eSOC
frequency in response to hypo-osmotic stimulation was similar to
sSOC frequency in neurons from P10 animals (0.49 ± 0.10⁄min, n =6
neurons), whereas the incidence of eSOCs was greater than sSOCs in
neurons from P20 animals (2.35 ± 0.63⁄min, n = 8 neurons). eSOC
frequency was signiﬁcantly different between the two ages (P < 0.01;
Fig. 3B). The occurrence of SOCs therefore exhibits both a nucleus-
speciﬁc distribution, being more prevalent in the VB than both the
dLGN and nRT, and a developmental emergence in the VB.
A
B
C
Fig. 1. TC neurons of the VB thalamus exhibit fast and slow transient GABAA receptor-mediated events. (A) Current trace displaying concomitant slow inward
currents (SICs) and slow outward currents (SOCs) in the same TC neuron. Representative SICs and SOCs are enlarged below. The bar graph shows the relative
frequency of SICs and SOCs in neurons examined. (B) (i) Current recording of spontaneous inhibitory postsynaptic currents (IPSCs) and SOCs from a TC neuron
recorded using pipettes containing 125 mm KCl. IPSPs can be seen during the grey portion of the trace, whilst a longer duration SOC is shown in black. (ii)
Recording from another cell, with expanded traces below displaying fast IPSCs (grey) and a much slower, and unusually large-amplitude, SOC (black). Cumulative
probability distributions of amplitude (upper) and time to peak (lower) for IPSCs (grey lines) and SOCs (black lines) are displayed on the right. (C) Traces from
experiments displaying spontaneously recorded events in the presence of tetrodotoxin (TTX; 1 lm, left), TTX + 0 mm extracellular Ca
2+ (middle) and the GABAA
antagonist SR95531 (25 lm, right). The bar graphs below show IPSC frequency (grey columns, left) and SOC frequency (black columns, right) normalized to
control for each experimental condition. *indicates P < 0.05; *** indicates P < 0.005.
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TC neurons of the VB contain relatively few GABAA receptor
subtypes. Synaptic receptors are comprised of a1b2c2-subunits and
are responsible for the generation of IPSCs, whereas a4b2d receptors
are present in the extrasynaptic membrane and generate tonic currents
(Wong & Snead, 2001; Belelli et al., 2005; Jia et al., 2005; Chandra
et al., 2006; Peden et al., 2008; Herd et al., 2009). Both the nucleus-
speciﬁc occurrence and developmental proﬁle of SOCs mirrors the
nucleus-speciﬁc distribution and postnatal development of the d-
subunit, i.e. the d-subunit is strongly expressed in the VB and dLGN
but is absent from the nRT (Pirker et al., 2000), and postnatally the d-
subunit is only present from P12 onward in rats (Laurie et al., 1992).
Because astrocytic glutamate release has been suggested to target
extrasynaptic receptors (Halassa et al., 2007), we therefore postulated
that SOCs are generated by the activation of d-subunit-containing
extrasynaptic receptors, as opposed to c2-subunit-containing synaptic
receptors. To test the role of different GABAA receptor populations in
the generation of SOCs we used the benzodiazepine site inverse
agonist b-CCB to target synaptic receptors, and the d-subunit-selective
agonist THIP to target extrasynaptic receptors. Application of b-CCB
(1 lm, n = 4 neurons) caused a signiﬁcant reduction in IPSC
amplitude (control – 93.90 ± 2.25 pA; b-CCB – 69.40 ± 2.17 pA,
608 and 533 events, respectively; P < 0.005; Fig. 4A). Evoked IPSCs
generated by stimulation of the nRTwere also signiﬁcantly reduced by
application of b-CCB (control – 493.62 ± 101.87 pA; b-CCB –
282.40 ± 94.92 pA, n = 6 neurons; P < 0.05; Fig. 4A). Analysis of
the effect of b-CCB on eSOCs (n = 4 neurons) showed a small, but
signiﬁcant, increase in amplitude (control – 89.70 ± 9.11 pA; b-CCB
– 98.20 ± 10.30 pA, 188 and 204 events, respectively; P < 0.05), but
no effect on frequency (control – 7.11 ± 1.11⁄min; b-CCB –
8.37 ± 1.63⁄min; Fig. 4B). Thus, IPSCs are indeed generated by
synaptic, c2-subunit-containing receptors, but SOCs are not dependent
on this receptor population. Application of the d-subunit-selective
agonist THIP (1 lm) resulted in a large tonic GABAA current
(285.96 ± 63.12 pA, n = 9 neurons), as described previously (Belelli
et al., 2005; Jia et al., 2005; Cope et al., 2009; Fig. 5A). Following
hACSF application in the presence of THIP, eSOCs occurred at a
reduced frequency (hACSF – 6.54 ± 1.72⁄min, n = 7 neurons;
hACSF + THIP – 1.56 ± 0.73⁄min, n = 8 neurons; P < 0.05;
Fig. 5A). In addition, the peak amplitude of eSOCs was signiﬁcantly
increased in the presence of THIP (hACSF – 165.04 ± 16.20 pA,
n = 286 events from seven neurons; hACSF + THIP –
214.98 ± 30.32 pA, n = 83 events from eight neurons; P < 0.005).
By comparison, the amplitude of the evoked IPSCs elicited by
stimulation of the nRT was not signiﬁcantly affected by THIP
(88.32 ± 8.10% of control, n = 5 neurons; Fig. 5A), indicating that
the reduction in eSOC frequency was not due to a simple shunting of
the membrane.
To further probe the role of d-subunit-containing receptors we
compared eSOCs in d KO mice and WT littermates. In WT mice,
hACSF application elicited eSOCs similar to those seen in rat VB TC
neurons (3.01 ± 0.84 eSOCs⁄min, n = 4 neurons; Fig. 5B). The
number of eSOCs was signiﬁcantly reduced in mice lacking the d-
subunit (1.12 ± 0.49 eSOCs⁄min, n = 5 neurons, P < 0.05; Fig. 5B),
underlined also by the signiﬁcant shift in the cumulative probability
distribution for inter-event intervals (WT – 8.94 ± 1.12 s, n = 150; d
KO – 22.86 ± 3.19 s, n = 83, P < 0.0001; Fig. 5C). In addition, the
kinetics of eSOCs were signiﬁcantly different between the d KO and
A
B
Fig. 2. Slow outward currents (SOCs) are evoked by hypo-osmotic stimulus. (A) Current trace from a TC neuron showing the increase in occurrence of SOCs
following bath application of hACSF. Several evoked SOCs (eSOCs) are expanded to the right. Note how application of SR95531 (25 lm) not only blocks eSOCs
but also causes an inward shift in current, revealing the presence of an outward tonic GABAA current. Cumulative probability distributions below compare the
amplitude (left) and time to peak (right) of eSOCs (grey) to spontaneous SOCs (sSOCs; black). On the far right is a bar graph comparing the amplitude of the tonic
current under control conditions (Ctrl) and following hypo-osmotic stimulus (Hypo). (B) Current trace showing that hypo-osmotic stimulus fails to induce eSOCs or
alter the holding current if SR95531 is applied beforehand. The bar graph on the right shows the effect of SR95531 on eSOC charge (Q) compared with hypo-
osmotic stimulus alone. ** indicates P < 0.001.
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29.43 ± 4.74 ms, n = 84, P < 0.001; WT sdecay – 74.19 ± 5.63 ms; d
KO sdecay – 53.68 ± 3.63 ms, P < 0.05; Fig. 5C).
Together, these data show that SOCs are generated by the activation
of extrasynaptic d-subunit-containing GABAA receptors, as they are:
(i) insensitive to the benzodiazepine site inverse agonist b-CCB,
which speciﬁcally targets c2-subunit-containing synaptic receptors;
(ii) sensitive to THIP, a preferential agonist at d-subunit-containing
receptors; and (iii) less frequent in mice following the genetic ablation
of the d-subunit.
The anti-epileptic vigabatrin augments SOCs
The lack of interneurons in the VB thalamus, the distinct properties of
SOCs and IPSCs, and the evoking of SOCs by hypo-osmotic stimuli
that are known to induce astrocytic transmitter release (Kimelberg
et al., 2006), along with a previous report showing that SOCs in the
olfactory bulb are dependent on astrocytic GABA release (Kozlov
et al., 2006),all point to SOCs in TC neurons of the VB thalamus being
generated by GABA released from astrocytes. Because GABA uptake
transporters in the VB thalamus are only present on astrocytes
(Barbaresi et al., 1986; De Biasi et al., 1998), we hypothesized that
inhibiting the catabolism of GABA by blocking the action of GABA
transaminase (GABA-T) should increase astrocytic GABA levels and
leadtoanincrease inSOCs,iftheyare indeedastrocytically derived.To
test this hypothesis we used the GABA-T inhibitor and anti-epileptic
vigabatrin. Treatment of slices with vigabatrin (200 lm) signiﬁcantly
increased both the frequency of sSOCs (control – 0.09 ± 0.035⁄min,
n = 7 neurons; vigabatrin 0.35 ± 0.09⁄min, n = 6 neurons; P < 0.05)
and the frequency of eSOCs (control – 2.95 ± 0.64⁄min, n =7
neurons; vigabatrin 6.21 ± 0.75⁄min, n = 5 neurons; P < 0.005;
Fig. 6A). In addition, the time to peak (control – 44.15 ± 3.40 ms,
n = 102 events from seven neurons; vigabatrin 85.69 ± 14.33 ms,
n = 194 events from ﬁve neurons; P < 0.001), but not the peak
amplitude (control 184.34 ± 24.37 pA; vigabatrin 228.76 ± 24.17 pA;
P > 0.05), of eSOCs was also signiﬁcantly affected. There was also a
trend in the frequency of both sSOCs and eSOCs to increase in a
vigabatrin-treated time-dependent manner (sSOCs – R = 0.52,
P = 0.07; eSOCs – R = 0.81, P < 0.005; Fig. 6C). Conversely, as
expected if the astrocyte–neuronal GABA cycle was perturbed, the
frequency of IPSCs declined in a time-dependent manner (R = )0.88,
P < 0.01), as previously described in dentate gyrus granule cells
(Overstreet & Westbrook, 2001), further highlighting the different
sources of GABA mediating IPSCs and SOCs (Fig. 6C).
We further probed the role of astrocytic GABA and GABA-T in the
generation of SOCs by testing the hypothesis that promoting GABA
uptake by increasing the extracellular GABA concentration should
lead to a build-up of astrocytic GABA, so that there is more available
for release. Slices were treated with 200 lm GABA in conjunction
with 200 lm vigabatrin, and the frequency of sSOCs in treated slices
was measured at varying time points. Increasing available GABA not
only increased sSOC frequency (vigabatrin – 0.35 ± 0.09⁄min, n =6
neurons; vigabatrin + GABA – 3.56 ± 0.56⁄min, n = 5 neurons;
P < 0.005), but also the time-dependent correlation of sSOCs with
vigabatrin treatment (R = 0.86, P < 0.001; Fig. 6B and C). Previous
studies with vigabatrin (Overstreet & Westbrook, 2001; Wu et al.,
2001, 2003) have suggested that increased intracellular GABA leads
to reversal of GATs. We tested whether vigabatrin increased SOCs via
AB
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Fig. 3. Nucleus-speciﬁc and age-dependent expression of slow outward currents (SOCs). (A) Schematic diagram showing the relative locations of the ventrobasal
(VB), dorsal lateral geniculate nucleus (dLGN) and nucleus reticularis thalami (nRT) in a slice preparation. Below, example traces of evoked SOCs (eSOCs) following
hypo-osmotic stimulus (grey line) in a TC neuron from the dLGN (upper trace), and in a neuron from the nRT (lower trace). (B) Summary bar graphs (upper row) of
spontaneous SOC (sSOC; black bars) and eSOC (grey bars) frequencies for the different nuclei. Below are plots of charge (Q) carried by eSOCs in the different nuclei.
Each symbol represents a single SOC, SOCs from the same cell are coded with the same symbol, time 0 denotes time of start of hypo-osmotic stimulus (grey bar in VB
example). (C) Trace showing eSOCs elicited by hypo-osmotic stimulus in a TC neuron recorded in a slice taken from an animal at P10. To the right are bar graphs
comparingthefrequencyofsSOCs(blackbars)andeSOCs(greybars)inTCneuronsoftheVBatP10(left)andP20(right).*indicatesP < 0.05;**indicatesP < 0.01.
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blockers NO711 and SNAP5114. Co-application of NO711 (20 lm)
and SNAP5114 (40 lm) increased the tonic GABAA current, consis-
tent with the block of GABA uptake, but had no effect on the increase
in frequency of sSOCs caused by treatment with vigabatrin and
GABA (vigabatrin + GABA – 1.25 ± 0.51⁄min; NO711, SNAP5114,
vigabatrin + GABA – 1.09 ± 0.47⁄min, n = 5 neurons; P > 0.05;
Fig. 6D). These data show that the increase in SOC frequency
following vigabatrin treatment is not due to reversal of GATs, and that
GABA uptake is unaffected as the block of GATs leads to an increase
in the tonic GABAA current, not a reduction as would be expected if
transporters were reversed.
Slow GABAergic hyperpolarizations
To determine the physiological manifestation and impact of SOCs, we
recorded from VB TC neurons in current-clamp mode. Under control
conditions we recorded two types of inhibitory activity: inhibitory
postsynaptic potentials (IPSPs) and spindle waves. Both these have
been previously described and shown to be derived from synaptic
afferent activity emanating from the nRTonto VB TC neurons (Gentet
& Ulrich, 2003).
IPSPs were seen as spontaneous transient events, caused a
)2.3 ± 0.06 mV (n = 56) hyperpolarization and had a time to peak
of 26.69 ± 0.51 ms. A mean IPSP averaged from 56 IPSPs had rise
and decay ﬁtted by a product of two exponentials (corr = 0.98 and
0.89, respectively; Fig. 7A). Such IPSPs correspond to VB thalamus
GABA release elicited by single nRTaction potentials (APs)(Gentet &
Ulrich, 2003). However, nRT neurons also produce VB inhibitory
hyperpolarizations by volleys of APs generated during nRT neuron
bursting. Such recurrent bursts occur during spindles, which are
3–4 Hz oscillatory activity generated by intrathalamic networks
between the inhibitory nRT neurons and excitatory TC neurons. We
therefore analysed the inhibitory hyperpolarizing events occurring
during spindles in VB TC neurons as a way of identifying inhibitory
events generated as the result of nRT AP bursts.
Hyperpolarizations had an amplitude of )3.57 ± 0.16 mV (n = 46)
and time to peak of 54 ± 0.93 ms. A mean spindle hyperpolarization
averaged from 46 events had rise (correlation 0.98) and decay ﬁtted by
products of two exponentials (corr = 0.93; Fig. 7B).
AB C
Fig. 5. Slow outward currents (SOCs) are mediated by extrasynaptic synaptic d-subunit-containing receptors. (A) Example traces of evoked SOCs (eSOCs)
generated by hACSF application following THIP (1 lm) exposure. Below are traces showing evoked IPSCs from the neuron before (black trace) and after (grey
trace) THIP application. To the right is a bar graph comparing evoked IPSC amplitude under control conditions (black column) and in the presence of THIP (grey
column) normalized to control. At the bottom is a bar graph (left) comparing eSOC frequency in the absence (black column) and presence (grey column) of THIP. To
the right is a cumulative probability plot of eSOC amplitude prior to (black line) and after (grey line) THIP application. (B) Current trace showing SOCs evoked by
hypo-osmotic stimulus in a VB TC neuron recorded from a wild-type (WT) mouse (top), and a d-subunit knockout (d KO) littermate (bottom, grey trace). Inset
shows expanded overlaid traces of the eSOCs indicated in the main traces. (C) Bar graph showing the frequency of eSOCs in WT (black column) and d KO (grey
column) mice. To the right and below are cumulative probability distribution plots comparing the inter-event intervals (IEIs), rise time constant and decay time
constant for d KO (grey lines) and WT mice (black lines). * indicates P < 0.05.
AB
Fig. 4. Slow outward currents (SOCs) are not mediated by synaptic
c2-subunit-containing receptors. (A) Current traces showing IPSCs under
control conditions (black) and following b-CCB (1 lm) application (grey) in
the same neuron. Below is a cumulative probability plot (left) of IPSC
amplitude in the absence (black line) and presence (grey line) of b-CCB. On the
right are traces showing the effect of b-CCB (grey) on evoked IPSCs elicited by
stimulation of the nRT, compared with control (black). (B) Current traces
showing the effects of hypo-osmotic stimulus in the absence (black trace) and
presence (grey trace) of b-CCB. Below is a cumulative distribution plot (left) of
eSOC amplitude in the absence (black line) and presence (grey line) of b-CCB.
The bar graph on the right shows the frequency of eSOCs in the two
experimental conditions.
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current-clamp in slices at 33 ºC that had been treated with 200 lm
vigabatrin to increase sSOC frequency. In these recordings we
observed slow hyperpolarizing potentials (SHPs) that hyperpolarized
the membrane potential away from action potential threshold (Fig. 7C).
SHPs caused a )3.21 ± 0.34 mV (n = 27) hyperpolarization and
A
B
C
D
Fig. 6. Slow outward currents (SOCs) are augmented by the anti-epileptic vigabatrin. (A) Current traces from TC neurons showing spontaneous activity and
response to a hypo-osmotic stimulus under control conditions (black trace), and in slices pre-treated with 200 lm vigabatrin (grey trace). Expanded spontaneous
SOCs (sSOCs) are as indicated (1 and 2). The bar graphs on the right illustrate the increase in frequency of sSOCs (top) and evoked SOCs (eSOCs; bottom)
following pre-treatment with vigabatrin. (B) Current trace from a TC neuron showing sSOCs following incubation with 200 lm vigabatrin and 200 lm
c-aminobutyric acid (GABA). Expanded sSOCs are as indicated (1 and 2). To the right is a bar graph comparing the effect of vigabatrin + GABA pre-treatment (dark
grey column) on sSOC frequency compared with vigabatrin pre-treatment alone (grey column). (C) The plot on the left illustrates the time dependence of vigabatrin
pre-treatment on sSOC frequency. Circles show sSOC frequency for different experiments in slices pre-treated with vigabatrin alone, triangles show experiments
from slices pre-treated with vigabatrin + GABA. The plot on the right shows the time-dependent effect of vigabatrin pre-treatment on inhibitory postsynaptic
currents (IPSCs). Plots are ﬁtted with linear regression lines. (D) Current trace showing the effect of co-application of NO711 and SNAP5114 (20 lm and 40 lm,
respectively) on holding current and sSOC frequency in a TC neuron from a vigabatrin-pre-treated slice. Application of SR95531 (25 lm) abolishes the transporter
blocker-induced increase in tonic GABAA current. The bar graphs on right show the effect of GABA transporter (GAT) blockers on tonic current amplitude (left) and
sSOC frequency (right) in the presence of vigabatrin and GABA alone, and together with NO711 and SNAP5114. * indicates P < 0.05; *** indicates P < 0.005.
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from 27 SHPs recorded from ﬁve cells had rise and decay time
constants that were ﬁtted by single exponentials (srise = 10.11 ms,
corr = 1.00; sdecay = 300 ms, corr = 0.92; Fig. 7B), supporting the
notion that SHPs are single events rather than compound bursts of
synaptic activity. As expected if SHPs were generated by SOCs,
application of SR95531 (20 lm) blocked all SHPs (Fig. 7C). SOCs
are therefore capable of modulating thalamic output through the
generation of SHPs that reduce TC neuron excitability. The slower
kinetics and the ﬁtting of the rise time with a single exponential
therefore distinguish SHPs from spindle hyperpolarizations and IPSPs
(Fig. 7D). The relationship between amplitude and area was steepest
for SHPs (Fig. 7D; R: IPSP = 0.69, spindle = 0.85, SHP = 0.71,
P < 0.001).
Discussion
Source of GABAergic SOCs
The comparatively simple anatomical and synaptic structure of the
rodent VB thalamus, combined with the conspicuous lack of
GABAergic interneurons, make it an attractive model for investigating
astrocytic function and, in particular, gliotransmitter release. Our data
from TC neurons show that SOCs are dependent on astrocytic GABA
release. Firstly, SOCs, unlike IPSCs, are not dependent on action
potentials, Ca
2+ entry or vesicular GABA release, indicating that they
are non-synaptically derived. Although alternate non-synaptic neuro-
nal GABA release mechanisms have been demonstrated (Koch &
Magnusson, 2009), and in the dLGN GABA can be released from
interneuron dendrites (Acuna-Goycolea et al., 2008), the absence of
interneurons in the VB thalamus, coupled to the fact that dendritic
GABA release is also vesicular and dependent on extracellular Ca
2+,
precludes this mechanism in accounting for our observations (Isaac-
son, 2001). Secondly, SOCs are induced by hypo-osmotic stimuli that
are an established method for inducing astrocytic amino acid release
(Kimelberg et al., 2006), and the method employed in the olfactory
bulb to elicit astrocytically mediated SOCs. Finally, selectively
targeting astrocyte GABA cycling by promoting GABA uptake by
GATs and inhibiting GABA catabolism increases the incidence of
SOCs but concomitantly decreases IPSC frequency, providing further
evidence that SOCs are astrocytically derived. The speciﬁc mechanism
involved in astrocytic GABA release remains to be identiﬁed, but the
most likely candidate is a volume-regulated anion channel, as
previously implicated in the olfactory bulb (Kozlov et al., 2006).
Another candidate may be the recently described bestrophin channel
(Lee et al., 2010). However, our data do demonstrate that reversed
GABA transport is not responsible for astrocytic GABA release, even
in conditions where astrocytic GABA levels are elevated following
block of GABA-T with vigabatrin or increased ambient GABA. This
is in contrast to previous ﬁndings where reversed GABA transport has
been observed under physiologically relevant conditions (Wu et al.,
2007), and in response to vigabatrin treatment (Wu et al., 2001, 2003),
although this is not a universal ﬁnding (Overstreet & Westbrook,
2001).
Astrocytic GABA release targets of d-subunit-containing
GABAA receptors
In addition to fast IPSCs and persistent tonic currents, TC neurons
therefore exhibit a third type of GABAA receptor-mediated inhibition
of intermediate duration, similar, but even slower, to the GABAA,slow
IPSCs previously described in hippocampal and cortical pyramidal
neurons that are mediated by an unusual GABAergic interneuron, the
neurogliaform cell (Banks et al., 1998; Szabadics et al., 2007; Olah
et al., 2009). In the thalamus, astrocytically released GABA appears to
target d-subunit-containing extrasynaptic GABAA receptors, rather
than c2-subunit-containing synaptic receptors, as SOCs were insen-
sitive to b-CCB, a benzodiazepine site, i.e. c2-subunit-speciﬁc, inverse
agonist, but were sensitive to modulation by the d-subunit-selective
agonist THIP, and were less frequent in mice lacking the d-subunit.
However, SOCs were not completely abolished in d KO mice, but this
is not surprising as extrasynaptic GABAA receptors of unknown
composition are present in TC neurons of d KO mice and generate a
residual tonic current (Cope et al., 2009; Herd et al., 2009). Indeed,
the subunit composition of this unknown receptor subtype may
explain the difference in SOC kinetics between d KO and WT mice.
To the best of our knowledge, therefore, this is the ﬁrst demonstration
that extrasynaptic GABAA receptors are more than simple detectors of
ambient GABA, but can mediate distinct, transient events in response
to GABA release, whatever the source. Furthermore, tonic current
amplitude increased substantially in response to hypo-osmotically
induced astrocytic GABA release, and there is every reason therefore
to believe that, despite the relatively low incidence of sSOCs,
astrocytes are a source of GABA for tonic GABAA currents under
physiologically relevant conditions.
We suggest that the THIP-induced decrease in SOC frequency, but
increase in amplitude, is due to the fact that THIP is a full agonist at
d-subunit-containing receptors, whereas GABA is only a partial
agonist (Brown et al., 2002; Storustovu & Ebert, 2006). The persistent
presence of THIP fully occupies the extrasynaptic receptors, not only
generating a large tonic current, but also preventing the binding of
GABA to the receptors for most of the time. Thus, THIP causes a
decrease in SOC frequency. On rare occasions, however, enough
GABA is released to displace THIP from the receptors, thereby
enabling the generation of SOCs. Because a substantial quantity of
GABA must be required to do this, only large events are observed, and
so there is a bias toward larger events in the presence of THIP. In
short, THIP competes against the endogenous agonist for occupancy
of the receptors, and GABA only succeeds in activating the receptor
when a suitably high concentration is released.
SOCs and GABA-T
The exacerbation of SOCs by vigabatrin highlights a potentially novel
therapeutic action for this anti-epileptic drug. Indeed, the concentra-
tion used in our study (200 lm) is within the plasma concentration
range seen in epileptic patients (132–518 lm; Sanchez-Alcaraz et al.,
1996). Vigabatrin remains a frontline treatment for a variety of seizure
types (Wheless et al., 2007), where increased GABAergic inhibition
may be beneﬁcial. However, vigabatrin treatment is contraindicated
for typical absence epilepsy, the major form of epilepsy associated
with cortico-TC networks. Indeed, vigabatrin has been shown to
exacerbate seizures in human absence epilepsy (Lortie et al., 1993;
Parker et al., 1998; Perucca et al., 1998), and in rodent models that
exhibit spike-and-wave discharges, the clinical hallmark of absence
seizures (Vergnes et al., 1984; Hosford & Wang, 1997; Bouwman
et al., 2007). These observations are consistent with the ﬁnding that
extrasynaptic GABAA receptor gain-of-function in the thalamus is
sufﬁcient to induce absence seizures (Cope et al., 2009), and that
administration of THIP can initiate spike-and-wave discharges (Far-
iello & Golden, 1987; Cope et al., 2009). Because astrocytic GABA
release also targets extrasynaptic receptors, SOCs may play an
important pathological role in the appearance of absence seizures.
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Whilst synaptic and, to a lesser extent, extrasynaptic GABA signalling
in the thalamus has been extensively studied, the physiological roles of
astrocytic GABA release in the thalamus are unclear. In our study, we
demonstrate that SOCs can occur spontaneously and have a physi-
ological impact, generating SHPs that reduce TC neuron excitability
through membrane hyperpolarization, and probably membrane shunt-
ing. SOCs therefore have the potential to shape TC neuron output.
It is noteworthy that the incidence of SOCs in thalamic nuclei is
inversely proportional to the presence of GABAergic neurons, with
SOCs more prevalent in the VB thalamus, a nucleus devoid of
thalamic interneurons, compared with the dLGN, and rarely occurring
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Fig. 7. GABAergic slow hyperpolarizing potentials (SHPs). (A) Current-clamp recording from a VB TC neuron illustrating typical spontaneous fast inhibitory
postsynaptic potentials (IPSPs). On the right is an averaged trace of IPSPs. Event decay is ﬁtted with a product of two exponentials (grey line). Inset illustrates
expanded rising phase of the mean IPSP ﬁtted with a product of two exponentials (grey line). (B) Recording in current-clamp of spindle oscillations recorded in a TC
neuron. Grey block denotes 1-s timeframe, illustrating stereotypical 4-Hz pattern. On the right is an averaged trace of spindle hyperpolarizations. Event decay is ﬁtted
with a product of two exponentials (grey line). Inset illustrates expanded rising phase of the mean hyperpolarization ﬁtted with a product of two exponentials (grey
line). (C) Current-clamp recording from a VB TC neuron following treatment with vigabatrin (200 lm). The highlighted SHPs are enlarged below. The average trace
of SHPs is shown to the right. Event decay is ﬁtted with a single exponential (grey line). Inset illustrates the expanded rising phase of the mean SHP ﬁtted with a single
exponential (grey line). The bar graph below shows the block of SHPs following the application of SR95531. (D) Superimposed average IPSPs (black trace), spindle
hyperpolarizations (grey trace) and SHPs (dark grey trace). (E) Plots of inhibitory event area against event amplitude. IPSPs (black), spindle hyperpolarizations (grey)
and SHPs (dark grey), ﬁtted with corresponding linear regression plots. Scale bar for traces, as illustrated. Current was injected to set Vm to depolarized ‘tonic’ mode
potentials. The stated Vm in current-clamp traces is indicated by a dark grey bar. The amplitude bar for all ﬁtted traces is 1 mV. * indicates P < 0.05.
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apparent low frequency of spontaneously occurring SOCs, which
might suggest that they are not physiologically relevant, their
increased incidence with age, and capacity to be upregulated by
GABA supply indicates that they may also be upregulated in some
physiological or pathophysiological conditions. Indeed by analogy
with other gliotransmitters (Parri et al., 2001; Henneberger et al.,
2010), it may also be expected that certain neurotransmitter systems
act to elicit astrocytic GABA release. Astrocytes may therefore
function as inhibitory cellular elements, and some of the roles of
thalamic GABAergic neurons may be adopted by astrocytes in the VB
thalamus. In this context, astrocytic glutamate release, which generates
SICs in the thalamus (Parri et al., 2001), has been shown to participate
in local, synchronized excitation of neurons in the hippocampus
(Angulo et al., 2004; Fellin et al., 2004) and nucleus accumbens
(D’Ascenzo et al., 2007), probably via extrasynaptic receptors. SOCs
may therefore be a mechanism for local, synchronized inhibition of
neurons as astrocytic GABA release would be expected to affect
multiple neurons within their domain (Halassa et al., 2007). Further-
more, abnormal astrocytic glutamate release may underlie neuronal
hypersynchronization (Tian et al., 2005), and therefore aberrant
astrocytic GABA release may also be pathological. Indeed the
physiological roles of extrasynaptic receptors are becoming increas-
ingly apparent, and aberrant extrasynaptic receptor function occurs in
several pathophysiological conditions (Maguire et al., 2005; Naylor
et al., 2005; Scimemi et al., 2005; Cope et al., 2009; Pavlov et al.,
2009; Rothman et al., 2009). However, the contribution of astrocytic
GABA signalling to these physiological and pathological behaviours
has yet to be determined.
In conclusion, our study describes a previously unrecognized form
of astrocyte–neuron GABA signalling in the thalamus that speciﬁcally
targets extrasynaptic GABAA receptors. Whilst the physiological roles
of this signalling remain to be elucidated, its augmentation by
vigabatrin suggests that astrocytic GABA release may be a therapeutic
target for some anti-epileptics, further highlighting the importance of
glia in both physiological and pathophysiological processes in the
CNS.
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